Brighton Jones LLC bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 808 shares of the biotechnology company's stock, valued at approximately $480,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Groupama Asset Managment acquired a new stake in Axon Enterprise in the third quarter valued at about $200,000. Massachusetts Financial Services Co. MA bought a new position in shares of Axon Enterprise in the third quarter worth about $120,553,000. International Assets Investment Management LLC acquired a new stake in shares of Axon Enterprise in the 3rd quarter valued at approximately $871,860,000. Westfield Capital Management Co. LP grew its holdings in shares of Axon Enterprise by 12.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company's stock valued at $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Finally, Assenagon Asset Management S.A. increased its position in Axon Enterprise by 328.7% during the 4th quarter. Assenagon Asset Management S.A. now owns 145,299 shares of the biotechnology company's stock worth $86,354,000 after purchasing an additional 111,405 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of analysts have weighed in on the stock. Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. The Goldman Sachs Group upped their target price on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a report on Monday. TD Cowen initiated coverage on Axon Enterprise in a report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target on the stock. JMP Securities raised their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a "market outperform" rating in a report on Thursday, October 31st. Finally, Needham & Company LLC lifted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of "Moderate Buy" and an average target price of $524.85.
View Our Latest Analysis on Axon Enterprise
Axon Enterprise Trading Down 0.9 %
NASDAQ AXON traded down $5.64 during trading hours on Monday, hitting $604.68. 458,123 shares of the company's stock were exchanged, compared to its average volume of 577,401. The firm has a market cap of $46.11 billion, a price-to-earnings ratio of 156.25, a PEG ratio of 6.09 and a beta of 1.04. The stock has a 50-day simple moving average of $617.65 and a 200 day simple moving average of $472.00. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 1-year low of $247.04 and a 1-year high of $698.67.
Insider Transactions at Axon Enterprise
In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the transaction, the director now owns 6,929 shares of the company's stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, President Joshua Isner sold 20,000 shares of the business's stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $606.15, for a total value of $12,123,000.00. Following the completion of the sale, the president now directly owns 208,166 shares of the company's stock, valued at $126,179,820.90. The trade was a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock valued at $30,721,337 in the last quarter. 6.10% of the stock is currently owned by company insiders.
About Axon Enterprise
(
Free Report)
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Featured Articles
Before you consider Axon Enterprise, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Axon Enterprise wasn't on the list.
While Axon Enterprise currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.